Lataa...
Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
The International Consensus in Time in Range (TIR) was recently released and defined the concept of the time spent in the target range between 70 and 180 mg/dL while reducing time in hypoglycemia, for patients using Continuous Glucose Monitoring (CGM). TIR was validated as an outcome measures for cl...
Tallennettuna:
| Julkaisussa: | Diabetol Metab Syndr |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7076978/ https://ncbi.nlm.nih.gov/pubmed/32190124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-020-00529-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|